Conexeu Sciences Inc. ("Conexeu" or the "Company"), a preclinical-stage biotechnology company advancing a tissue-restoration platform, today announced the completion of the P.R.O.O.F phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results